Skip to main content

Would some cannabinoids ameliorate symptoms of autism?

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524–538

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Green JJ, Hollander E (2010) Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics 7:250–257

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010) Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107:4389–4394

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Sala M, Braida D, Lentini D et al (2011) Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 69:875–882

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Wainwright A, Rutter AR, Seabrook GR, Reilly K, Olivier KR (2004) Discrete expression of TRPV2 within the hypothalamo-neurohypophysial system: implications for regulatory activity within the hypothalamic–pituitary–adrenal axis. J Comp Neurol 474:24–42

    PubMed  Article  Google Scholar 

  6. 6.

    Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Peterson-Zeitz KR (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288:306–313

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM (2008) TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28:6231–6238

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G (2009) Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytother Res 23:597–602

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Onaivi ES, Benno R, Halpern T et al (2011) Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. Curr Neuropharmacol 9:209–214

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Belzung C, Leman S, Vourc’h P, Andres C (2005) Rodents model for autism: a critical review. Drug Discov Today Dis Models 2:93–101

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rami Bou Khalil.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bou Khalil, R. Would some cannabinoids ameliorate symptoms of autism?. Eur Child Adolesc Psychiatry 21, 237–238 (2012). https://doi.org/10.1007/s00787-012-0255-z

Download citation

Keywords

  • Autism Spectrum Disorder
  • Autism Spectrum Disorder
  • Vasopressin
  • Oxytocin
  • Dorsal Root Ganglion Neuron